Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer-Reference-Cited by-同舟云学术

Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer

Published:2016-07-05 Issue:11 Volume:108 Page:djw148
ISSN:0027-8874
Container-title:Journal of the National Cancer Institute
language:en
Short-container-title:JNCI J Natl Cancer Inst

Author:

ter Brugge Petra,Kristel Petra,van der Burg Eline,Boon Ute,de Maaker Michiel,Lips Esther,Mulder Lennart,de Ruiter Julian,Moutinho Catia,Gevensleben Heidrun,Marangoni Elisabetta,Majewski Ian,Jóźwiak Katarzyna,Kloosterman Wigard,van Roosmalen Markus,Duran Karen,Hogervorst Frans,Turner Nick,Esteller Manel,Cuppen Edwin,Wesseling Jelle,Jonkers Jos

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/108/11/djw148/17314806/djw148.pdf

Reference44 articles.

1. Triple-Negative Breast Cancer

2. Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens

3. Promoter Hypermethylation and BRCA1 Inactivation in Sporadic Breast and Ovarian Tumors

4. Enhanced sensitivity to cisplatin and gemcitabine in Brca1-deficient murine mammary epithelial cells;Alli;BMC Pharmacol.,2011

5. High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs

Cited by 163 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LAMB3: Central role and clinical significance in neoplastic and non-neoplastic diseases;Biomedicine & Pharmacotherapy;2024-09

2. Increased oxygen stimulation promotes chemoresistance and phenotype shifting through PLCB1 in gliomas;Drug Resistance Updates;2024-09

3. Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer;Frontiers in Oncology;2024-07-29

4. KAT6A Condensates Impair PARP1 Trapping of PARP Inhibitors in Ovarian Cancer;Advanced Science;2024-07-08

5. FANCM promotes PARP inhibitor resistance by minimizing ssDNA gap formation and counteracting resection inhibition;Cell Reports;2024-07